Recovery & injury

Tendons, joints, injuries, wound healing and recovery from training. Ranked by evidence grade, then user score. Each grade is for the use named on the card, which may not be this goal.

12 of 12 peptides shown

  1. B

    1.Cerebrolysin

    Moderate human evidence · for cognitive and functional recovery in dementia, stroke rehabilitation and traumatic brain injury (the nationally authorised uses); healthy-person nootropic use is untested

    FDA Not approved WADA Not named
    User score
    Outcomes: Positive 4 of 13 (31%), Mixed 3 of 13 (23%), Negative 1 of 13 (8%), No effect 1 of 13 (8%), Unclear 4 of 13 (31%)
    Men 45–60: 0 · everyone: 13 reports · approximate

    Why it’s listed: graded use mentions it.

  2. C

    2.Ipamorelin

    Preliminary human data · for raising growth hormone for sleep and body composition

    FDA Not approved WADA Prohibited (S2.2.4)
    User score
    Outcomes: Positive 34 of 48 (71%), Mixed 8 of 48 (17%), Negative 4 of 48 (8%), No effect 2 of 48 (4%)
    Men 45–60: 2 · everyone: 48 reports · approximate

    Why it’s listed: 14 of 48 user reports mention recovery.

  3. C

    3.BPC-157

    Preliminary human data · for injury/tendon healing and gut repair (injected or oral)

    FDA Not approved WADA Prohibited (S0)
    User score
    Outcomes: Positive 12 of 21 (57%), Mixed 3 of 21 (14%), Negative 1 of 21 (5%), Unclear 5 of 21 (24%)
    Men 45–60: 3 · everyone: 21 reports · approximate

    Why it’s listed: graded use mentions it; 9 of 21 user reports mention injury healing; 8 of 21 user reports mention joint tendon.

  4. C

    4.CJC-1295

    Preliminary human data · for raising growth hormone for body composition, recovery and sleep

    FDA Not approved WADA Prohibited (S2.2.4)
    User score
    Outcomes: Positive 6 of 12 (50%), Mixed 1 of 12 (8%), Negative 2 of 12 (17%), Unclear 3 of 12 (25%)
    Men 45–60: 1 · everyone: 12 reports · approximate

    Why it’s listed: graded use mentions it.

  5. C

    5.ARA-290

    Preliminary human data · for neuropathic pain / small-fibre nerve repair

    FDA Not approved WADA Prohibited (S2.1.5)
    User scoretoo few reports (5)
    Men 45–60: 0 · everyone: 5 reports · approximate

    Why it’s listed: graded use mentions it; substance class mentions it; 2 of 5 user reports mention injury healing.

  6. D

    6.KPV

    Preclinical only · for gut and skin anti-inflammatory use

    FDA Not approved WADA Likely prohibited (S0)
    User score
    Outcomes: Positive 11 of 32 (34%), Mixed 11 of 32 (34%), Negative 5 of 32 (16%), No effect 2 of 32 (6%), Unclear 3 of 32 (9%)
    Men 45–60: 0 · everyone: 32 reports · approximate

    Why it’s listed: 11 of 32 user reports mention inflammation.

  7. D

    7.TB-500

    Preclinical only · for injected TB-500 fragment for injury recovery

    FDA Not approved WADA Prohibited (S2.3)
    User score
    Outcomes: Positive 4 of 11 (36%), Negative 3 of 11 (27%), No effect 2 of 11 (18%), Unclear 2 of 11 (18%)
    Men 45–60: 0 · everyone: 11 reports · approximate

    Why it’s listed: graded use mentions it; 4 of 11 user reports mention injury healing; 4 of 11 user reports mention joint tendon.

  8. D

    8.LL-37

    Preclinical only · for injected or nasal use for infections, biofilms and CIRS

    FDA Not approved WADA Prohibited (S0)
    User score
    Outcomes: Positive 4 of 23 (17%), Mixed 6 of 23 (26%), Negative 3 of 23 (13%), No effect 2 of 23 (9%), Unclear 6 of 23 (26%)
    Men 45–60: 0 · everyone: 23 reports · approximate

    Why it’s listed: graded use mentions it.

  9. D

    9.Dihexa

    Preclinical only · for nootropic / cognitive repair

    FDA Not approved WADA Likely prohibited (S0)
    User scoretoo few reports (9)
    Men 45–60: 0 · everyone: 9 reports · approximate

    Why it’s listed: graded use mentions it.

  10. D

    10.Follistatin-344

    Preclinical only · for injected protein for muscle growth

    FDA Not approved WADA Prohibited (S4.3)
    User scoretoo few reports (9)
    Men 45–60: 0 · everyone: 9 reports · approximate

    Why it’s listed: page tags mentions it.

  11. D

    11.IGF-1 LR3

    Preclinical only · for muscle growth and recovery

    FDA Not approved WADA Prohibited (S2.3)
    User scoretoo few reports (6)
    Men 45–60: 0 · everyone: 6 reports · approximate

    Why it’s listed: graded use mentions it.

  12. D

    12.PEG-MGF

    Preclinical only · for muscle recovery and growth

    FDA Not approved WADA Prohibited (S2.3)
    User scoretoo few reports (7)
    Men 45–60: 1 · everyone: 7 reports · approximate

    Why it’s listed: graded use mentions it.

User reports are anecdata, not evidence: self-selected, unverified, often combined with other compounds.